Maternal macronutrient intake and gestational diabetes: systematic review of prospective observational studies and dose-response meta-analyses
Young CD, Garratt MG, Athukorala T, et al.
BMC Med. Pub. online 11 Apr 2026.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Clinic for athletes with type 1 diabetes: evaluation of a structured clinical care model for physically active individuals
Pedersen S, Mortensen M, Bach E, et al.
Diabetes Obes Cardiometab Care. Pub. online 7 Apr 2026.
Leggi
Automated insulin delivery systems in type 2 diabetes mellitus: a systematic review and meta-analysis
Hespanhol LC, Agarwal S, Carvalhal G, et al.
Diabetes Care. Pub. online 6 Apr 2026.
Leggi
Glucagon-like peptide-1 receptor agonists reduce major adverse cardiovascular events and worsening heart failure in patients with heart failure: an umbrella meta-analysis
Sun C, Meng C, Yuan Y, et al.
BMC Endocr Disord. Pub. online 2 Apr 2026.
Leggi
Differences in clinical manifestations and islet autoantibodies by age in adult-onset type 1 diabetes
Karakus KE, Clayton MG, Baschal EE, et al.
Diabetes Care. Pub. online 2 Apr 2026.
Leggi
Cardiovascular-kidney-metabolic syndrome stages, echocardiographic characteristics, and heart failure risk: the atherosclerosis risk in communities study
Højbjerg Lassen MC, Ostrominski JW, Claggett BL, et al.
Circulation. Pub. online 1 Apr 2026.
Leggi
Impact of real time, flash and retrospective continuous glucose monitoring on feto‐maternal outcomes in women with gestational diabetes and pre‐gestational diabetes: a systematic review and meta‐analysis with trial sequential analysis of randomized controlled trials
Dutta D, Jena S, Mahajan K, et al.
Diabetes Obes Metab. Pub. online 7 Apr 2026.
Leggi
Beyond weight: systems biology and precision medicine redefine obesity as a multidimensional disease
Liu Y, Yang Y, Zhu L, Peng W
Diabetes Obes Metab. Pub. online 7 Apr 2026.
Leggi
Obesity and metabolic dysfunction-associated steatotic liver disease (MASLD): a literature review on pathophysiology and treatment
Romanos M, Garcia Cordova JM, Villamarin J, et al.
Diabetes Obes Metab. Pub. online 6 Apr 2026.
Leggi
Cost-effectiveness of apoB, non–HDL-C, and LDL-C goals for primary prevention lipid-lowering therapy
Luebbe S, Sniderman AD, Moran AE, et al.
JAMA. Pub. online 8 Apr 2026.
Leggi